GBCS — Selectis Health Income Statement
0.000.00%
Last trade - 00:00- $5.37m
- $36.85m
- $39.49m
- 56
- 81
- 23
- 54
Annual income statement for Selectis Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 20.9 | 29.3 | 40.6 | 36.8 | 39.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 15.8 | 29.7 | 40.9 | 45.7 | 42.2 |
| Operating Profit | 5.1 | -0.378 | -0.333 | -8.96 | -2.73 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.96 | -2.24 | -2.4 | -3.97 | -2.42 |
| Net Income After Taxes | 2.96 | -2.24 | -2.4 | -3.97 | -2.42 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.96 | -2.25 | -2.4 | -3.97 | -2.42 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.93 | -2.28 | -2.43 | -4 | -2.45 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.453 | -0.951 | -0.779 | -1.31 | -1.49 |